Tenet Healthcare (NYSE:THC) Stock Price Expected to Rise, Guggenheim Analyst Says

Key Points

• Guggenheim raised Tenet Healthcare’s price target from $283 to $307 and maintained a “buy” rating, implying 11.61% potential upside. Analysts overall rate the stock “Moderate Buy,” with a consensus target of $278.45.
• Tenet reported strong quarterly results, earning $6.12 per share versus the $4.26 consensus estimate and generating $6.04 billion in revenue, up 6.8% year over year.
• The stock opened at $275.06, near its 52-week high of $283.05, while insiders sold $35.1 million of shares during the last quarter; institutional investors own 95.44% of the company.

Tenet Healthcare (NYSE:THC - Get Free Report) had its price target hoisted by investment analysts at Guggenheim from $283.00 to $307.00 in a report issued on Friday, Benzinga reports. The firm currently has a "buy" rating on the stock. Guggenheim's target price would suggest a potential upside of 11.61% from the stock's previous close.

A number of other brokerages also recently weighed in on THC. Royal Bank Of Canada boosted their target price on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an "outperform" rating in a research note on Monday, July 27th. BMO Capital Markets started coverage on Tenet Healthcare in a report on Tuesday, September 22nd. They set a "market perform" rating and a $265.00 target price on the stock. Leerink Partners reissued an "outperform" rating and issued a $309.00 price target on shares of Tenet Healthcare in a report on Friday, September 18th. The Goldman Sachs Group reissued a "buy" rating and set a $305.00 target price on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Finally, Truist Financial boosted their price target on Tenet Healthcare from $270.00 to $290.00 and gave the company a "buy" rating in a report on Tuesday, July 28th. Eighteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $278.45.

Tenet Healthcare Stock Performance

Tenet Healthcare stock opened at $275.06 on Friday. The stock has a fifty day moving average price of $264.27 and a two-hundred day moving average price of $218.73. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. Tenet Healthcare has a 52-week low of $157.58 and a 52-week high of $283.05. The firm has a market capitalization of $22.15 billion, a P/E ratio of 10.61, a P/E/G ratio of 1.04 and a beta of 1.20.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The firm had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. During the same period last year, the firm posted $4.02 EPS. The firm's quarterly revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, analysts anticipate that Tenet Healthcare will post 21.04 EPS for the current fiscal year.

Insider Activity at Tenet Healthcare

In other news, Director Nadja West sold 1,152 shares of the firm's stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $258.80, for a total transaction of $298,137.60. Following the completion of the sale, the director owned 23,653 shares in the company, valued at approximately $6,121,396.40. This trade represents a 4.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Richard Mark sold 10,000 shares of the business's stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $263.42, for a total value of $2,634,200.00. Following the sale, the director owned 25,121 shares of the company's stock, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 131,199 shares of company stock worth $35,065,587 in the last quarter. 0.97% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds have recently added to or reduced their stakes in the stock. PeakShares LLC raised its stake in Tenet Healthcare by 3.3% in the first quarter. PeakShares LLC now owns 1,693 shares of the company's stock valued at $319,000 after purchasing an additional 54 shares in the last quarter. Sanctuary Advisors LLC grew its holdings in Tenet Healthcare by 0.5% during the 1st quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company's stock worth $2,246,000 after acquiring an additional 57 shares during the last quarter. Applied Finance Capital Management LLC grew its stake in shares of Tenet Healthcare by 3.8% in the first quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company's stock worth $310,000 after purchasing an additional 60 shares during the last quarter. Mather Group LLC. increased its stake in shares of Tenet Healthcare by 126.9% in the third quarter. Mather Group LLC. now owns 118 shares of the company's stock valued at $30,000 after buying an additional 66 shares during the period. Finally, Davidson Capital Management Inc. increased its position in Tenet Healthcare by 1.0% during the 3rd quarter. Davidson Capital Management Inc. now owns 6,712 shares of the company's stock valued at $1,715,000 after purchasing an additional 67 shares during the period. Institutional investors own 95.44% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation is a Dallas-based healthcare services company that operates hospitals, outpatient facilities and other healthcare businesses across the United States. Its operations include acute care hospitals, specialty hospitals, ambulatory surgery centers and related outpatient services.

Through its United Surgical Partners International subsidiary, Tenet is one of the major operators and developers of ambulatory surgery centers in the United States. These facilities provide same-day surgical procedures and other outpatient care across a range of medical specialties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.